Re: Adhesive Anti-fibrotic Interfaces on Diverse Organs.

Eur Urol

Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czechia; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.

Published: November 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2024.10.029DOI Listing

Publication Analysis

Top Keywords

adhesive anti-fibrotic
4
anti-fibrotic interfaces
4
interfaces diverse
4
diverse organs
4
adhesive
1
interfaces
1
diverse
1
organs
1

Similar Publications

Unveiling the fibrotic puzzle of endometriosis: An overlooked concern calling for prompt action.

F1000Res

December 2024

Division of Reproductive Biology, Department of Reproductive Science, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.

Endometriosis is a benign, estrogen-dependent, persistent chronic inflammatory heterogeneous condition that features fibrotic adhesions caused by periodic bleeding. The characteristic ectopic lesions are marked by a widely spread dense fibrotic interstitium comprising of fibroblasts, myofibroblasts, collagen fibers, extracellular proteins, inflammatory cells, and active angiogenesis. Fibrosis is now recognized as a critical component of endometriosis because of which current treatments, such as hormonal therapy and surgical excision of lesions are largely ineffective with severe side effects, high recurrence rates, and significant morbidity.

View Article and Find Full Text PDF

Re: Adhesive Anti-fibrotic Interfaces on Diverse Organs.

Eur Urol

November 2024

Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czechia; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.

View Article and Find Full Text PDF

New Insights into the Pleiotropic Actions of Dipeptidyl Peptidase-4 Inhibitors Beyond Glycaemic Control.

touchREV Endocrinol

October 2024

Department of Medical Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt.

Dipeptidyl peptidase-4 (DPP-4) is a multifunctional serine ectopeptidase that cleaves and modifies a plethora of substrates, including regulatory peptides, cytokines and chemokines. DPP-4 is implicated in the regulation of immune response, viral entry, cellular adhesion, metastasis and chemotaxis. Regarding its numerous substrates and extensive expression inside the body, multitasking DPP-4 has been assumed to participate in different pathophysiological mechanisms.

View Article and Find Full Text PDF
Article Synopsis
  • Plant callus, particularly from Hypericum perforatum, is rich in beneficial compounds like hyperforin and hypericin that have antibacterial and anti-inflammatory properties, making them useful for wound healing.
  • A new wound dressing made from poly(vinyl alcohol), chitosan, and alginate is infused with Hypericum perforatum callus extract (HPCE) and has shown favorable properties such as high swelling capacity and mechanical strength, enhancing tissue regeneration.
  • In laboratory and animal studies, this dressing has been proven to be biocompatible, promote healing processes like re-epithelialization and collagen deposition, and reduce the risk of fibrosis after wounds heal, while also combating antibiotic-resistant bacteria.
View Article and Find Full Text PDF

Therapeutic role of physalin A in the pathogenesis of Graves' orbitopathy.

Immunopharmacol Immunotoxicol

December 2024

Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea.

Background: Graves' orbitopathy (GO) is an autoimmune condition that causes serious ocular symptoms; its treatment strategies are limited. Physalin A is a phytosterol that has shown various therapeutic properties, including anti-inflammatory and anti-fibrotic effects. In this study, we investigated whether physalin A could inhibit inflammation, fibrosis, hyaluronan (hyaluronic acid) production, and adipogenesis, which are crucial to the pathogenesis of GO.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!